Drug delivery specialist Atacama Labs today launches its new proprietary drug delivery technology for licensing worldwide through its commercial partner Bridgehead International. PDG Technology™ offers a solution to the challenges faced by pharmaceutical companies in the development of solid oral dosage forms by replacing existing development and manufacturing methods to create significantly faster development times and improved formulations.
The unique capabilities of pneumatic dry granulation (PDG Technology™) have been demonstrated in a variety of in-depth evaluation studies with leading pharmaceutical companies. "We have proven capabilities of our technology in collaboration with top tier pharmaceutical companies, showing that in a single day's work with PDG Technology, we successfully created formulations that clearly met the target criteria of our clients, whose own efforts over several months using traditional methods had been less successful," said Petri Rahja, Director of Delivery, Atacama Labs.
"Atacama Labs's novel technology and formulation services can provide significant benefits to both pharmaceutical and biotech companies. The PDG Technology™ process can appreciably reduce the time to market for solid dose forms, with positive impacts on profitability. We are delighted to partner with Atacama Labs and are convinced that our unique mix of commercial, technical and IP experience will help them maximize the uptake of this product throughout the pharmaceutical industry," said Dr Fiona Paton of Bridgehead International.
PDG Technology enables flexible modification of drug load, disintegration time and tablet hardness. It is suitable for a wide range of APIs with different physicochemical properties, including heat labile and moisture sensitive drugs. Very high drug loading can be achieved, even with 'difficult' APIs and combinations. Stability and taste masking is excellent. PDG Technology™ can also be used in conjunction with other technologies, such as sustained release, fast release and coating.
Line extensions based on PDG Technology™ can extend patent life and brand franchises. Effective product life cycle management is a critical survival strategy today, as pharmaceutical and biotechnology companies compete to maintain market share and maximize commercial returns.
